Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Intas PharmaceuticalsIntas Pharmaceuticals
VS
Ipca Laboratories LimitedIpca Laboratories Limited
Intas Pharmaceuticals

Intas Pharmaceuticals

Sarkhej Gandhinagar Highway, Near Sola Bridge, Ahmedabad, Gujarat, IN

Last Update: 18/09/2026

View Profile
Between 750 and 799
https://intaspharma.com
795/1000Fair

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of su...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:18,773
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0
Ipca Laboratories Limited

Ipca Laboratories Limited

125 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, IN, 400067

Last Update: 13/09/2026

View Profile
Between 750 and 799
https://www.ipca.com/
771/1000Fair

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,559
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Intas Pharmaceuticals

Intas Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Ipca Laboratories Limited

Ipca Laboratories Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intas Pharmaceuticals in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Ipca Laboratories Limited in 2026.

Incidents

Incident History - Intas Pharmaceuticals (X = Date, Y = Severity)

Intas Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Ipca Laboratories Limited (X = Date, Y = Severity)

Ipca Laboratories Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Intas Pharmaceuticals

Intas Pharmaceuticals

Incidents
No explicit notable incidents reported.
Ipca Laboratories Limited

Ipca Laboratories Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has the best AI Cybersecurity Score ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has experienced more cyber incidents in the past ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has experienced more cyber incidents this year ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has experienced at least one ransomware attack ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has experienced at least one data breach ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has experienced at least one targeted cyberattack ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has experienced at least one vulnerability ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one holds the most compliance certifications ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one holds the fewest compliance certifications ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has the most subsidiaries ?
Between Intas Pharmaceuticals company and Ipca Laboratories Limited company, which one has the largest number of employees ?
Between Intas Pharmaceuticals and Ipca Laboratories Limited, which company holds both SOC 2 Type 1 certifications ?
Between Intas Pharmaceuticals and Ipca Laboratories Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Intas Pharmaceuticals or Ipca Laboratories Limited ?
Which company is PCI DSS compliant - Intas Pharmaceuticals or Ipca Laboratories Limited ?
Between Intas Pharmaceuticals and Ipca Laboratories Limited, which company complies with HIPAA regulations for healthcare data ?
Between Intas Pharmaceuticals and Ipca Laboratories Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-113705
SUMMARY

A vulnerability was determined in a2aproject a2a-rs up to 0.4.3. This issue affects some unknown processing of the file a2a-server/src/error.rs. Executing a manipulation can lead to information exposure through error message. The attack can be executed remotely. This patch is called 713b943af94ab2d521d483b841618b97a2e78a4d. A patch should be applied to remediate this issue.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 5.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-9825
SUMMARY

IBM Cyber Fraud 1.0.0 through 1.0.2 has a missing secure attribute allowing sensitive cookies to be transmitted over unencrypted connections, potentially enabling an attacker to intercept session data through network-based attacks.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94402
SUMMARY

IBM Carbon Charts 0.4.0 through 1.27.19 is vulnerable to cross-site scripting. The MeterChart component's Title.truncateTitle() function re-inserts a substring of user-supplied label text into the DOM via an unsanitized innerHTML write when the title exceeds the available container width. A remote attacker could exploit this vulnerability to execute arbitrary JavaScript in the victim's browser session.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
IMPACT SCORE
2.7
EXPLOITABILITY
2.8
CVE-2026-93888
SUMMARY

IBM Sterling Connect Direct for Unix 6.4.0.0 through 6.4.0.6 and 6.3.0.0 through 6.3.0.7 apnotify utility is vulnerable to a code injection due to insufficient validation of user input.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-93744
SUMMARY

IBM i 7.3, 7.4, 7.5, and 7.6 could allow an unathenticated remote attacker to bypass security restrictions due to improper access control. By sending a specially crafted HTTP request to any URL within the Navigator application prior to authentication, a bad actor could exploit this vulnerability to alter server-side session security state.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
3.9